The ethics of testing a test: Randomized trials of the health impact of diagnostic tests for infectious diseases

Clinical Infectious Diseases

Volumn 55, Issue 11, 2012, Pages 1522-1526

  Dowdy, David W ^a,b   Gounder, Celine R ^b,c   Corbett, Elizabeth L ^e,f   Ngwira, Lucky G ^f   Chaisson, Richard E ^a,b,c   Merritt, Maria W ^a,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Center for Tuberculosis Research   (United States)

^c Division of Infectious Diseases   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE CONTROL; DRUG SENSITIVITY; EQUIPOISE; ETHICS; FEASIBILITY STUDY; HEALTH PROGRAM; HUMAN; INFECTION; INFORMED CONSENT; MALARIA; MORBIDITY; MORTALITY; PATIENT SATISFACTION; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY;

COMMUNICABLE DISEASES; DIAGNOSTIC TESTS, ROUTINE; ETHICS, RESEARCH; HUMANS; INFORMED CONSENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS;

EID: 84869043405     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis736     Document Type: Article

References (27)

1. Jani IV, Sitoe NE, Alfai ER, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet 2011; 378:1572-9.
2. Abba K, Deeks JJ, Olliaro P, et al. Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Cochrane Database Syst Rev 2011; 7:CD008122.
3. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011; 377:1495-505.
4. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-15.
5. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978; 299: 926-30.
6. Dowdy DW, Cattamanchi A, Steingart KR, Pai M. Is scale-up worth it? challenges in economic analysis of diagnostic tests for tuberculosis. PLoS Medicine 2011; 8:e1001063.
7. World Health Organization. Guidelines for the treatment of malaria. 2nd ed. Geneva, Switzerland: World Health Organization, 2010.
8. Kass NE. An ethics framework for public health. Am J Public Health 2001; 91:1776-82.
9. Andriole GL, Crawford ED, Grubb RL 3rd, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360:1310-9.
10. Stall N, Rubin T, Michael JS, et al. Does solid culture for tuberculosis influence clinical decision making in India? Int J Tuberc Lung Dis 2011; 15:641-6.
11. Donner A, Klar N. Design and analysis of cluster randomization trials in health research. London, United Kingdom: Arnold, 2000.
12. Weijer C, Grimshaw JM, Taljaard M, et al. Ethical issues posed by cluster randomized trials in health research. Trials 2011; 12:100.
13. Binik A, Weijer C, McRae AD, et al. Does clinical equipoise apply to cluster randomized trials in health research? Trials 2011; 12:118.
14. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000; 283:2701-11.
15. Emanuel EJ, Wendler D, Grady C. An ethical framework for biomedical research. In: Emanuel EJ, Grady C, Crouch RA, Lie RK, Miller FGWendler D, eds. The Oxford textbook of clinical research ethics. New York, NY: Oxford University Press, 2008.
16. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987; 317:141-5.
17. Joffe S, Truog R. Equipoise and randomization. In: Emanuel EJ, Grady C, Crouch RA, Lie RK, Miller FG, Wendler D, eds. The Oxford textbook of clinical research ethics. New York NY: Oxford University Press, 2008:245-60.
18. Trebucq A, Enarson DA, Chiang CY, et al. Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how? Int J Tuberc Lung Dis 2011; 15:1567-72.
19. Singh JA, Bhan A. The ethics of national tuberculosis programmes in low-income countries not rolling out Xpert® MTB/RIF. Int J Tuberc Lung Dis 2011; 15:1563.
20. Bonaa KH, Njolstad I, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006; 354:1578-88.
21. Moore DAJ, Evans CAW, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006; 355:1539-50.
22. Dowdy DW, Steingart KR, Pai M. Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis. PLoS Med 2011; 8:e1001074.
23. Hamer DH, Ndhlovu M, Zurovac D, et al. Improved diagnostic testing and malaria treatment practices in Zambia. JAMA 2007; 297:2227-31.
24. Uzochukwu BS, Onwujekwe E, Ezuma NN, Ezeoke OP, Ajuba MO, Sibeudu FT. Improving rational treatment of malaria: perceptions and influence of RDTs on prescribing behaviour of health workers in southeast Nigeria. PLoS One 2011; 6:e14627.
25. McRae AD,Weijer C, Binik A, et al. When is informed consent required in cluster randomized trials in health research? Trials 2011; 12:202.
26. Davis JL, Katamba A, Vasquez J, et al. Evaluating tuberculosis case detection via real-time monitoring of tuberculosis diagnostic services. Am J Respir Crit Care Med 2011; 184:362-7.
27. Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med 1980; 302:1109-17.